The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness
Open accessAbstract
Identification of drug resistance before it becomes a public health concern requires a clear distinction between what constitutes a normal and a suboptimal treatment response. A novel method of analyzing drug efficacy studies in human helminthiases is proposed and used to investigate recent claims of atypical responses to ivermectin in the treatment of River Blindness. The variability in the rate at which Onchocerca volvulus microfilariae repopulate host's skin following ivermectin treatment is quantified using an individual-based onchocerciasis mathematical model. The model estimates a single skin repopulation rate for every host sampled, allowing reports of suboptimal responses to be statistically compared with responses from populations with no prior exposure to ivermectin. Statistically faster rates of skin repopulation were observed in 3 Ghanaian villages (treated 12–17 times), despite the wide variability in repopulation rates observed in ivermectin-naïve populations. Another village previously thought to have high rates of skin repopulation was shown to be indistinguishable from the normal treatment response. The model is used to generate testable hypotheses to identify whether atypical rates of skin repopulation by microfilariae could result from low treatment coverage alone or provide evidence of decreased ivermectin efficacy. Further work linking phenotypic poor responses to treatment with parasite molecular genetics markers will be required to confirm drug resistance. Limitations of the skin-snipping method for estimating parasite load indicates that changes in the distribution of microfilarial repopulation rates, rather than their absolute values, maybe a more sensitive indicator of emerging ivermectin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug resistance in nematodes of veterinary importance: a status report
Kaplan, R. M. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.08.001 · Cited by 1,276 · cited 1×
“Anthelmintic resistance is already a major problem in veterinary parasitic nematodes (1), and suboptimal responses to treatment have been reported in a number of human helminthiases (2–8).”
BackgroundFailure of Mebendazole in Treatment of Human Hookworm Infections in the Southern Region of Mali
De Clercq, D., Sacko, M., Behnke, J., Gilbert, F., Dorny, P., & Vercruysse, J. (1997) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1997.57.25 · Cited by 212
Cited by
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686
Mechanical Strain and Bone Cell Function: A Review
Ehrlich, P. J., & Lanyon, L. E. (2002) · Osteoporosis International · doi:10.1007/s001980200095 · Cited by 512
Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus
Osei-Atweneboana, M. Y., Awadzi, K., Attah, S. K., Boakye, D. A., Gyapong, J. O., & Prichard, R. K. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000998 · Cited by 300
Self-citationMoxidectin: an oral treatment for human onchocerciasis
Milton, P., Hamley, J. I. D., Walker, M., & Basáñez, M.-G. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792772 · Cited by 211
Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States
Bowman, D. D. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-138 · Cited by 82
Metadata
- Authors
- Churcher, T. S., Pion, S. D. S., Osei-Atweneboana, M. Y., Prichard, R. K., Awadzi, K., Boussinesq, M., Collins, R. C., Whitworth, J. A., & Basáñez, M.-G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16716-16721
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2071685455
- Cited by
- 213
- References
- 2
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.